The PRMT5/WDR77 complex restricts hepatitis E virus replication

PLoS Pathog. 2023 Jun 5;19(6):e1011434. doi: 10.1371/journal.ppat.1011434. eCollection 2023 Jun.

Abstract

Hepatitis E virus (HEV) is one of the main pathogenic agents of acute hepatitis in the world. The mechanism of HEV replication, especially host factors governing HEV replication is still not clear. Here, using HEV ORF1 trans-complementation cell culture system and HEV replicon system, combining with stable isotope labelling with amino acids in cell culture (SILAC) and mass spectrometry (MS), we aimed to identify the host factors regulating HEV replication. We identified a diversity of host factors associated with HEV ORF1 protein, which were putatively responsible for viral genomic RNA replication, in these two cell culture models. Of note, the protein arginine methyltransferase 5 (PRMT5)/WDR77 complex was identified in both cell culture models as the top hit. Furthermore, we demonstrated that PRMT5 and WDR77 can specifically inhibit HEV replication, but not other viruses such as HCV or SARS-CoV-2, and this inhibition is conserved among different HEV strains and genotypes. Mechanistically, PRMT5/WDR77 can catalyse methylation of ORF1 on its R458, impairing its replicase activity, and virus bearing R458K mutation in ORF1 relieves the restriction of PRMT5/WDR77 accordingly. Taken together, our study promotes more comprehensive understanding of viral infections but also provides therapeutic targets for intervention.

MeSH terms

  • COVID-19
  • Hepatitis E virus* / genetics
  • Hepatitis E*
  • Humans
  • Protein-Arginine N-Methyltransferases / genetics
  • SARS-CoV-2
  • Virus Replication / physiology

Substances

  • PRMT5 protein, human
  • Protein-Arginine N-Methyltransferases

Grants and funding

This work is supported by National Natural Science Foundation of China (82272302, 82241077 and 32070153 to QD; 32200111 to XJ), Beijing Municipal Natural Science Foundation (Z220018 to QD), 2030 Innovation Tsinghua Initiative (100021067 to QD), The Postdoctoral Science Foundation of China (2021TQ0182 to XJ), Shuimu Tsinghua Scholar Program (2021SM107 to XJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.